Nexthera Capital as of Dec. 31, 2018
Portfolio Holdings for Nexthera Capital
Nexthera Capital holds 23 positions in its portfolio as reported in the December 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| SPDR S&P Biotech (XBI) | 14.8 | $36M | 499k | 71.75 | |
| BioMarin Pharmaceutical (BMRN) | 12.0 | $29M | 341k | 85.15 | |
| Novartis (NVS) | 11.2 | $27M | 316k | 85.81 | |
| Teva Pharmaceutical Industries (TEVA) | 10.7 | $26M | 1.7M | 15.42 | |
| Heron Therapeutics (HRTX) | 8.8 | $21M | 819k | 25.94 | |
| Audentes Therapeutics | 6.7 | $16M | 764k | 21.32 | |
| Immunomedics | 5.3 | $13M | 895k | 14.27 | |
| Bausch Health Companies (BHC) | 5.1 | $12M | 665k | 18.47 | |
| Insmed (INSM) | 4.5 | $11M | 839k | 13.12 | |
| Global Blood Therapeutics In | 3.8 | $9.1M | 222k | 41.05 | |
| Horizon Pharma | 3.2 | $7.7M | 396k | 19.54 | |
| D Stemline Therapeutics | 2.8 | $6.8M | 712k | 9.50 | |
| Exelixis (EXEL) | 2.5 | $6.1M | 308k | 19.67 | |
| Cymabay Therapeutics | 2.3 | $5.6M | 715k | 7.87 | |
| Chiasma | 1.4 | $3.3M | 1.1M | 3.11 | |
| Catalyst Biosciences | 1.2 | $3.0M | 376k | 7.89 | |
| Deciphera Pharmaceuticals | 1.1 | $2.6M | 122k | 20.99 | |
| Sutro Biopharma (STRO) | 0.9 | $2.3M | 250k | 9.02 | |
| Zosano Pharma Corp | 0.7 | $1.7M | 799k | 2.12 | |
| Athenex | 0.6 | $1.6M | 123k | 12.69 | |
| Osmotica Pharmaceuticals (RVLPQ) | 0.4 | $935k | 121k | 7.75 | |
| Mediwound Ltd cmn | 0.2 | $425k | 105k | 4.06 | |
| Vaccinex | 0.0 | $62k | 17k | 3.64 |
